#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Carcinoid tumour Osteosarcoma recurrent Chondrodystrophy Encephalopathy neonatal Idiopathic inflammatory myopathy Familial haemophagocytic lymphohistiocytosis Pseudoxanthoma elasticum HER2 gene amplification Hodgkin's disease refractory Squamous cell carcinoma of head and neck Endometrial cancer recurrent Philadelphia positive acute lymphocytic leukaemia Chronic lymphocytic leukaemia refractory Non-small cell lung cancer recurrent C3 glomerulopathy More trials…

    Learn about Rare Diseases

    Langerhans’ cell histiocytosis – Diagnostics Pelizaeus-Merzbacher disease – Diagnostics Retinitis pigmentosa – Trials in Disease Alport’s syndrome Castleman’s disease Proteus syndrome – Treatment Congenital generalised lipodystrophy – Basic Information Ewing’s sarcoma recurrent – Life with Disease Biotinidase deficiency – Basic Information Primary hyperoxaluria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vixarelimab CAL101 Bi-1910 SEPOFARSEN Lecanemab Gedatolisib Defactinib Chlorambucil Ceftolozane Arginine Hydrochloride Cebsulfase Alfa Dyp688 Enpatoran Lactose Eclitasertib BENZYDAMINE HYDROCHLORIDE Gadobutrol VERTEPORFIN Gsk4011499 Glucose Monohydrate More therapies…

    Learn about Your Condition

    Apathy Hereditary optic atrophy Tricuspid valve disease Abdominal wall pain Hypertension Femur fracture Vertebrobasilar stroke Restless legs syndrome Langerhans cell sarcoma Hyperinsulinism Carcinoid tumour pulmonary Eosinophilic oesophagitis Post procedural oedema Bacterial infection Device related infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Peripheral T-cell lymphoma unspecified

  • Study on Azacitidine, Roginolisib, and Golcadomide for Patients with Relapsed or Refractory Peripheral T-Cell Lymphomas

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Golcadomide
    • Azacitidine
    • Roginolisib
    France

  • Study on the Effectiveness and Safety of Belinostat and Pralatrexate with Drug Combination for Newly Diagnosed Peripheral T-Cell Lymphoma Patients

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Belinostat
    • Pralatrexate
    • Cyclophosphamide
    Germany Hungary Italy Poland Spain

  • Study on the Benefits of Autologous Stem Cell Transplantation for Patients with Peripheral T-cell Lymphoma Using Etoposide and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Brentuximab Vedotin
    • Methylprednisolone Hemisuccinate
    • Cyclophosphamide Monohydrate
    Belgium France

  • Study of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Lacutamab
    • Gemcitabine
    • Oxaliplatin
    Belgium France Germany Spain

  • Study on the Safety and Effects of Tolinapant in Patients with Advanced Solid Tumors and Lymphomas

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cutaneous T-cell lymphoma
    • Peripheral T-cell lymphoma unspecified
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Tolinapant Lactate
    Italy Spain

  • Study on Brentuximab Vedotin and Drug Combination for Patients with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Brentuximab Vedotin
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    France Italy Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!